{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:22:33Z","timestamp":1783689753394,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Intensive Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jointm.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T21:30:33Z","timestamp":1719351033000},"page":"100-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Influence of hydrocortisone infusion method on the clinical outcome of patients with septic shock: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3848-8589","authenticated-orcid":false,"given":"Yuting","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0833-2248","authenticated-orcid":false,"given":"Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jointm.2024.05.001_bib0001","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/CCM.0000000000002512","article-title":"The impact of the sepsis-3 septic shock definition on previously defined septic shock patients","volume":"45","author":"Sterling","year":"2017","journal-title":"Critical Care Medicine"},{"issue":"3","key":"10.1016\/j.jointm.2024.05.001_bib0002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Medicine"},{"issue":"8","key":"10.1016\/j.jointm.2024.05.001_bib0003","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jointm.2024.05.001_bib0004","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/CCM.0b013e3181d455b6","article-title":"Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study","volume":"38","author":"Castellanos-Ortega","year":"2010","journal-title":"Critical Care Medicine"},{"issue":"7","key":"10.1016\/j.jointm.2024.05.001_bib0005","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0000000000000318","article-title":"Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response*","volume":"42","author":"Katsenos","year":"2014","journal-title":"Critical Care Medicine"},{"issue":"2","key":"10.1016\/j.jointm.2024.05.001_bib0006","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"The New England Journal of Medicine"},{"issue":"11","key":"10.1016\/j.jointm.2024.05.001_bib0007","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"10.1016\/j.jointm.2024.05.001_bib0008","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2110-5820-1-7","article-title":"Corticosteroids for severe sepsis: an evidence-based guide for physicians","volume":"1","author":"Annane","year":"2011","journal-title":"Ann Intensive Care"},{"issue":"9","key":"10.1016\/j.jointm.2024.05.001_bib0009","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1016\/j.jointm.2024.05.001_bib0010","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jointm.2024.05.001_bib0011","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5005\/jp-journals-10071-23501","article-title":"Hyperglycemia risk evaluation of hydrocortisone intermittent boluses vs continuous infusion in septic shock: a retrospective study","volume":"25","author":"Mitwally","year":"2021","journal-title":"The Indian Journal of Critical Care Medicine"},{"issue":"4","key":"10.1016\/j.jointm.2024.05.001_bib0012","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00134-007-0540-3","article-title":"Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients","volume":"33","author":"Weber-Carstens","year":"2007","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.jointm.2024.05.001_bib0013","doi-asserted-by":"crossref","first-page":"k3284","DOI":"10.1136\/bmj.k3284","article-title":"Corticosteroid therapy for sepsis: a clinical practice guideline","volume":"362","author":"Lamontagne","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jointm.2024.05.001_bib0014","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2021","journal-title":"The Journal of Clinical Epidemiology"},{"key":"10.1016\/j.jointm.2024.05.001_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/cc3452","article-title":"Impact of continuous versus bolus low-dose hydrocortisone application on blood glucose in septic shock patients","volume":"9","author":"Weber-Carstens","year":"2005","journal-title":"Critical Care"},{"key":"10.1016\/j.jointm.2024.05.001_bib0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.ccm.0000424331.10013.8e","article-title":"Dexmedetomidine administration during CPR decreases the sympathetic response after return of spontaneous circulation","volume":"40","author":"Badugu","year":"2012","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.jointm.2024.05.001_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ccm.0000458483.09531.27","article-title":"Outcomes in septic shock patients treated with continuous versus bolus stress-dose hydrocortisone","volume":"42","author":"Liszewski","year":"2014","journal-title":"Critical Care Medicine"},{"issue":"11","key":"10.1016\/j.jointm.2024.05.001_bib0018","doi-asserted-by":"crossref","first-page":"S527","DOI":"10.1097\/01.CCM.0000142983.15421.11","article-title":"Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-based review","volume":"32","author":"Keh","year":"2004","journal-title":"Critical Care Medicine"},{"issue":"2","key":"10.1016\/j.jointm.2024.05.001_bib0019","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00134-007-0868-8","article-title":"Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions","volume":"34","author":"Kaufmann","year":"2008","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.jointm.2024.05.001_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IDR.S387995","article-title":"Nomogram prediction model of hypernatremia on mortality in critically ill patients","volume":"16","author":"Qi","year":"2023","journal-title":"Infection and Drug Resistance"},{"key":"10.1016\/j.jointm.2024.05.001_bib0021","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jointm.2024.05.001_bib0022","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"29","key":"10.1016\/j.jointm.2024.05.001_bib0023","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1002\/sim.3428","article-title":"The exact distribution of Cochran's heterogeneity statistic in one-way random effects meta-analysis","volume":"27","author":"Biggerstaff","year":"2008","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.jointm.2024.05.001_bib0024","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"2","key":"10.1016\/j.jointm.2024.05.001_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychological Methods"},{"issue":"1","key":"10.1016\/j.jointm.2024.05.001_bib0026","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/cc5696","article-title":"Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial","volume":"11","author":"Loisa","year":"2007","journal-title":"Critical Care"},{"issue":"1","key":"10.1016\/j.jointm.2024.05.001_bib0027","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5492\/wjccm.v6.i1.65","article-title":"Timing, method and discontinuation of hydrocortisone administration for septic shock patients","volume":"6","author":"Ibarra-Estrada","year":"2017","journal-title":"World Journal of Critical Care Medicine"},{"issue":"4","key":"10.1016\/j.jointm.2024.05.001_bib0028","first-page":"252","article-title":"Evaluation of hydrocortisone continuous infusion versus intermittent boluses in resolution of septic shock","volume":"42","author":"Hoang","year":"2017","journal-title":"P T"},{"issue":"5","key":"10.1016\/j.jointm.2024.05.001_bib0029","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/SHK.0000000000001316","article-title":"Comparison between continuous and intermittent administration of hydrocortisone during septic shock: a randomized controlled clinical trial","volume":"52","author":"Tilouche","year":"2019","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.jointm.2024.05.001_bib0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0897190019850937","article-title":"Hydrocortisone continuous infusion versus bolus dose on glycemic control in critically ill subjects","volume":"34","author":"Coles","year":"2021","journal-title":"The Journal of Pharmacy Practice"},{"issue":"3","key":"10.1016\/j.jointm.2024.05.001_bib0031","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/aer.aer_115_22","article-title":"Hyperglycemia risk evaluation of hydrocortisone intermittent boluses versus continuous infusion in septic shock: a prospective randomized trial","volume":"16","author":"Ram","year":"2022","journal-title":"Anesthesia, Essays and Researches"},{"issue":"12","key":"10.1016\/j.jointm.2024.05.001_bib0032","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002243.pub4","article-title":"Corticosteroids for treating sepsis in children and adults","volume":"12","author":"Annane","year":"2019","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jointm.2024.05.001_bib0033","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","article-title":"2024 focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia","volume":"52","author":"Chaudhuri","year":"2024","journal-title":"Critical Care Medicine"},{"issue":"3","key":"10.1016\/j.jointm.2024.05.001_bib0034","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Critical Care Medicine"},{"issue":"19","key":"10.1016\/j.jointm.2024.05.001_bib0035","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.2174\/138161208784980626","article-title":"Adrenal insufficiency in sepsis","volume":"14","author":"Annane","year":"2008","journal-title":"Current Pharmaceutical Design"},{"issue":"12","key":"10.1016\/j.jointm.2024.05.001_bib0036","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1097\/CCM.0b013e3181b083f7","article-title":"Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis","volume":"37","author":"Falciglia","year":"2009","journal-title":"Critical Care Medicine"},{"issue":"12","key":"10.1016\/j.jointm.2024.05.001_bib0037","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002243.pub4","article-title":"Corticosteroids for treating sepsis","volume":"2015","author":"Annane","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.jointm.2024.05.001_bib0038","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10157-020-01967-9","article-title":"Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case-control study","volume":"25","author":"Imaizumi","year":"2021","journal-title":"Clinical and Experimental Nephrology"},{"issue":"4","key":"10.1016\/j.jointm.2024.05.001_bib0039","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.chest.2016.06.006","article-title":"ICU-acquired weakness: a rehabilitation perspective of diagnosis, treatment, and functional management","volume":"150","author":"Zorowitz","year":"2016","journal-title":"Chest"}],"container-title":["Journal of Intensive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X24000719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X24000719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T08:47:23Z","timestamp":1736066843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667100X24000719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2667100X24000719"],"URL":"https:\/\/doi.org\/10.1016\/j.jointm.2024.05.001","relation":{},"ISSN":["2667-100X"],"issn-type":[{"value":"2667-100X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of hydrocortisone infusion method on the clinical outcome of patients with septic shock: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Intensive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jointm.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}